These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22395687)

  • 41. The effect of ivacaftor in adolescents with cystic fibrosis (G551D mutation): an exercise physiology perspective.
    Saynor ZL; Barker AR; Oades PJ; Williams CA
    Pediatr Phys Ther; 2014; 26(4):454-61. PubMed ID: 25251804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new model for drug development using a multi-stakeholder consortium.
    Hall AK
    BMJ; 2014 Mar; 348():g1850. PubMed ID: 24603569
    [No Abstract]   [Full Text] [Related]  

  • 43. New drugs 2013, Part I.
    Hussar DA
    Nursing; 2013 Feb; 43(2):36-46; quiz 47-8. PubMed ID: 23302940
    [No Abstract]   [Full Text] [Related]  

  • 44. Straight talk with...Sir John Chisholm. Interview by Elie Dolgin.
    Chisholm J
    Nat Med; 2013 Aug; 19(8):955. PubMed ID: 23921732
    [No Abstract]   [Full Text] [Related]  

  • 45. Straight talk with...Donna Ambrosino. Interview by Elie Dolgin.
    Ambrosino D
    Nat Med; 2011 Mar; 17(3):240. PubMed ID: 21383712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Straight talk with... María Blasco. Interview by Elie Dolgin.
    Blasco M
    Nat Med; 2011 Aug; 17(8):909. PubMed ID: 21818075
    [No Abstract]   [Full Text] [Related]  

  • 47. The Louis and Artur Lucian Award in Cardiovascular Diseases at McGill University.
    Genest J; Hébert TE; Martin J
    Circ Res; 2016 Oct; 119(9):975-977. PubMed ID: 27737939
    [No Abstract]   [Full Text] [Related]  

  • 48. Straight talk with...George Koob. Interview by Elie Dolgin.
    Koob G
    Nat Med; 2014 Jan; 20(1):8. PubMed ID: 24398952
    [No Abstract]   [Full Text] [Related]  

  • 49. Raising money for cystic fibrosis: At what price?
    Janvier A
    CMAJ; 2010 Jul; 182(10):1079. PubMed ID: 20624880
    [No Abstract]   [Full Text] [Related]  

  • 50. Ivacaftor for patients with cystic fibrosis.
    Wainwright CE
    Expert Rev Respir Med; 2014 Oct; 8(5):533-8. PubMed ID: 25148205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystic fibrosis drug Vertex's latest triumph.
    Ledford H
    Nat Biotechnol; 2012 Mar; 30(3):201-2. PubMed ID: 22398597
    [No Abstract]   [Full Text] [Related]  

  • 52. Excitement mounts for first disease-modifying cystic fibrosis drugs.
    Opar A
    Nat Rev Drug Discov; 2011 Jul; 10(7):479-80. PubMed ID: 21720393
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA deems in vitro data on mutations sufficient to expand cystic fibrosis drug label.
    Ratner M
    Nat Biotechnol; 2017 Jul; 35(7):606. PubMed ID: 28700545
    [No Abstract]   [Full Text] [Related]  

  • 54. Personalized medicine. New cystic fibrosis drug offers hope, at a price.
    Kaiser J
    Science; 2012 Feb; 335(6069):645. PubMed ID: 22323790
    [No Abstract]   [Full Text] [Related]  

  • 55. Straight talk with... Robert Beall. Interviewed by Elie Dolgin.
    Beall R
    Nat Med; 2012 Mar; 18(3):335. PubMed ID: 22395687
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.